Shanghai Fosun Pharmaceutical Partners with Nanning City to Broaden Collaboration in Biopharma and Beyond

Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196，HKG: 2196), a Chinese pharmaceutical heavyweight, has entered into a strategic partnership with Nanning City in Guangxi province, China’s gateway to the ASEAN region. The collaboration aims to explore opportunities in biopharmaceuticals, intelligent manufacturing, finance and insurance, commerce, culture, tourism, and other sectors. The financial specifics of the agreement have not been disclosed.- Flcube.com